It could be, but remember what I said first. That is the model, and if we follow that model—which I no longer do—it will lead to unaffordable pricing, so again, we have that tension, right? If we increase the VC funding in Canada and build lots of little biotechs, all the professors would be driving Ferraris. Somebody is paying for it, and it's us. This is going to achieve a breaking point maybe in about five years; I don't know.
Then why not invent a different way of inventing new medicines? There's still going to be as much economic payoff; it will just be in a different way, and we'll have savings in the health system.